Barclays analyst Andrew Mok raised the firm’s price target on Tenet Healthcare to $156 from $147 and keeps an Overweight rating on the shares as part of a Q2 earnings preview for the managed care space.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Uber, Birkenstock among additions to Deutsche Bank ‘Fresh Money List’ for Q3
- Tenet Healthcare price target raised to $155 from $150 at Deutsche Bank
- Tenet Healthcare price target raised to $150 from $126 at Deutsche Bank
- Tenet Healthcare price target raised to $140 from $107 at JPMorgan
- Tenet Healthcare initiated with an Outperform at Baird